14 drug(s) with this reaction
88,138 total reports
Headache has been reported as an adverse reaction across 14 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 88,138 adverse event reports mention headache in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with headache, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have headache listed in their FDA adverse event reports, sorted by report count:
In addition to headache, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
14 drug(s) manufactured by Abbvie Inc have headache listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, GLECAPREVIR AND PIBRENTASVIR, FENOFIBRATE, and others.
There are a combined 88,138 reports of headache across 14 Abbvie Inc drug(s) in the FDA adverse event database.